The Interpretation of 2021 ACOG Practice Bulletin: Prediction and Prevention of Spontaneous Preterm Birth

doi:10.12280/gjfckx.20211040

Abstract

Abstract:

Preterm birth is the main cause of neonatal death and short-term and long-term complications, of which 70%~80% are spontaneous preterm birth (SPB), and the other 20%~30% are iatrogenic preterm birth. The rate of preterm birth has been increasing in recent years and efforts were made to improve the prognosis of preterm birth. In August 2021, the American College of Obstetricians and Gynecologists (ACOG) issued the practice bulletin No. 234 "Prediction and Prevention of Spontaneous Preterm Birth", covering the increased preterm birth rate and its associated risk factors, measures to reduce the risk of preterm birth by intervening modifiable risk factors, strategies to assess the risk of preterm birth individually and prevent preterm birth. This paper interpreted the main points of its recommendation in order to provide evidence-based basis for clinical practice related to preterm delivery.

Key words: Premature birth, Forecasting, Guidebooks, Spontaneous preterm birth, Prevention, ACOG

JIANG Xiang, YING Hao. The Interpretation of 2021 ACOG Practice Bulletin: Prediction and Prevention of Spontaneous Preterm Birth[J]. Journal of International Obstetrics and Gynecology, 2021, 48(6): 684-690.

References 35

[1]	Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth[J]. Obstet Gynecol, 2012,120(4):964-973. doi: 10.1097/AOG.0b013e3182723b1b. doi: 10.1097/AOG.0b013e3182723b1b
[2]	胡娅莉. 早产临床诊断与治疗指南(2014)[J]. 中华妇产科杂志, 2014,49(7):481-485. doi: 10.3760/cma.j.issn.0529-567x.2014.07.001. doi: 10.3760/cma.j.issn.0529-567x.2014.07.001
[3]	Al-Alaiyan S. Call to establish a national lower limit of viability[J]. Ann Saudi Med, 2008,28(1):1-3. doi: 10.5144/0256-4947.2008.1. doi: 10.5144/0256-4947.2008.1 pmid: 18299657
[4]	Deng K, Liang J, Mu Y, et al. Preterm births in China between 2012 and 2018: an observational study of more than 9 million women[J]. Lancet Glob Health, 2021,9(9):e1226-e1241. doi: 10.1016/S2214-109X(21)00298-9. doi: 10.1016/S2214-109X(21)00298-9
[5]	Pergialiotis V, Bellos I, Antsaklis A, et al. Presence of amniotic fluid sludge and pregnancy outcomes: A systematic review[J]. Acta Obstet Gynecol Scand, 2020,99(11):1434-1443. doi: 10.1111/aogs.13893. doi: 10.1111/aogs.13893
[6]	Romero R, Kusanovic JP, Espinoza J, et al. What is amniotic fluid ′sludge′?[J]. Ultrasound Obstet Gynecol, 2007,30(5):793-798. doi: 10.1002/uog.5173. doi: 10.1002/uog.5173
[7]	Friedman AM, Srinivas SK, Parry S, et al. Can transabdominal ultrasound be used as a screening test for short cervical length?[J]. Am J Obstet Gynecol, 2013, 208(3):190.e1-e7. doi: 10.1016/j.ajog.2012.12.021. doi: 10.1016/j.ajog.2012.12.021
[8]	Esplin MS, Elovitz MA, Iams JD, et al. Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women[J]. JAMA, 2017,317(10):1047-1056. doi: 10.1001/jama.2017.1373. doi: 10.1001/jama.2017.1373 pmid: 28291893
[9]	Orzechowski KM, Boelig RC, Baxter JK, et al. A universal transvaginal cervical length screening program for preterm birth prevention[J]. Obstet Gynecol, 2014,124(3):520-525. doi: 10.1097/AOG.0000000000000428. doi: 10.1097/AOG.0000000000000428 pmid: 25162252
[10]	ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy[J]. Obstet Gynecol, 2018,132(1):e44-e52. doi: 10.1097/AOG.0000000000002708. doi: 10.1097/AOG.0000000000002708
[11]	Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate[J]. N Engl J Med, 2003,348(24):2379-2385. doi: 10.1056/NEJMoa035140. doi: 10.1056/NEJMoa035140
[12]	Jarde A, Lutsiv O, Beyene J, et al. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis[J]. BJOG, 2019,126(5):556-567. doi: 10.1111/1471-0528.15566 doi: 10.1111/1471-0528.15566
[13]	Jain V, McDonald SD, Mundle WR, et al. Guideline No. 398: Progesterone for Prevention of Spontaneous Preterm Birth[J]. J Obstet Gynaecol Can, 2020,42(6):806-812. doi: 10.1016/j.jogc.2019.04.012. doi: 10.1016/j.jogc.2019.04.012
[14]	Blackwell SC, Gyamfi-Bannerman C, Biggio JR Jr, et al. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial[J]. Am J Perinatol, 2020,37(2):127-136. doi: 10.1055/s-0039-3400227. doi: 10.1055/s-0039-3400227
[15]	Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials[J]. Lancet, 2021,397(10280):1183-1194. doi: 10.1016/S0140-6736(21)00217-8. doi: 10.1016/S0140-6736(21)00217-8
[16]	Saccone G, Khalifeh A, Elimian A, et al. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials[J]. Ultrasound Obstet Gynecol, 2017,49(3):315-321. doi: 10.1002/uog.17245. doi: 10.1002/uog.17245 pmid: 27546354
[17]	Grobman WA, Thom EA, Spong CY, et al. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm[J]. Am J Obstet Gynecol, 2012, 207(5): 390.e1-e8. doi: 10.1016/j.ajog.2012.09.013. doi: 10.1016/j.ajog.2012.09.013
[18]	Berghella V, Ciardulli A, Rust OA, et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data[J]. Ultrasound Obstet Gynecol, 2017,50(5):569-577. doi: 10.1002/uog.17457. doi: 10.1002/uog.17457 pmid: 28295722
[19]	Conde-Agudelo A, Romero R, Da Fonseca E, et al. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis[J]. Am J Obstet Gynecol, 2018,219(1):10-25. doi: 10.1016/j.ajog.2018.03.028. doi: S0002-9378(18)30243-6 pmid: 29630885
[20]	Ehsanipoor RM, Seligman NS, Saccone G, et al. Physical Examination-Indicated Cerclage: A Systematic Review and Meta-analysis[J]. Obstet Gynecol, 2015,126(1):125-135. doi: 10.1097/AOG.0000000000000850. doi: 10.1097/AOG.0000000000000850 pmid: 26241265
[21]	Conde-Agudelo A, Romero R, Nicolaides KH. Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2020,223(1):42-65.e2. doi: 10.1016/j.ajog.2019.12.266. doi: S0002-9378(19)33085-6 pmid: 32027880
[22]	Dodd JM, Grivell RM, OBrien CM, et al. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy[J]. Cochrane Database Syst Rev, 2017,10(10):CD012024. doi: 10.1002/14651858.CD012024.pub2. doi: 10.1002/14651858.CD012024.pub2
[23]	Megli C, Combs CA, Venkataramanan R, et al. Recurrent Preterm Birth Reduction by 17-Hydroxyprogesterone Caproate in Dichorionic/Diamniotic Twin Gestation[J]. Am J Perinatol, 2020 Dec 15. Epub ahead of print. doi: 10.1055/s-0040-1721713. doi: 10.1055/s-0040-1721713
[24]	Romero R, Conde-Agudelo A, El-Refaie W, et al. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data[J]. Ultrasound Obstet Gynecol, 2017,49(3):303-314. doi: 10.1002/uog.17397. doi: 10.1002/uog.17397 pmid: 28067007
[25]	D′Antonio F, Berghella V, Di Mascio D, et al. Role of progesterone, cerclage and pessary in preventing preterm birth in twin pregnancies: A systematic review and network meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2021,261:166-177. doi: 10.1016/j.ejogrb.2021.04.023. doi: 10.1016/j.ejogrb.2021.04.023
[26]	Roman A, Rochelson B, Fox NS, et al. Efficacy of ultrasound-indicated cerclage in twin pregnancies[J]. Am J Obstet Gynecol, 2015, 212(6):788.e1-e6. doi: 10.1016/j.ajog.2015.01.031. doi: 10.1016/j.ajog.2015.01.031
[27]	Saccone G, Rust O, Althuisius S, et al. Cerclage for short cervix in twin pregnancies: systematic review and meta-analysis of randomized trials using individual patient-level data[J]. Acta Obstet Gynecol Scand, 2015,94(4):352-358. doi: 10.1111/aogs.12600. doi: 10.1111/aogs.12600
[28]	Roman A, Zork N, Haeri S, et al. Physical examination-indicated cerclage in twin pregnancy: a randomized controlled trial[J]. Am J Obstet Gynecol, 2020,223(6):902.e1-902.e11. doi: 10.1016/j.ajog.2020.06.047. doi: 10.1016/j.ajog.2020.06.047
[29]	McIntosh J, Feltovich H, Berghella V, et al. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention[J]. Am J Obstet Gynecol, 2016,215(3):B2-B7. doi: 10.1016/j.ajog.2016.04.027. doi: 10.1016/j.ajog.2016.04.027
[30]	Fox NS, Gelber SE, Kalish RB, et al. The recommendation for bed rest in the setting of arrested preterm labor and premature rupture of membranes[J]. Am J Obstet Gynecol, 2009,200(2):165.e1-e6. doi: 10.1016/j.ajog.2008.08.007. doi: 10.1016/j.ajog.2008.08.007
[31]	Yost NP, Owen J, Berghella V, et al. Effect of coitus on recurrent preterm birth[J]. Obstet Gynecol, 2006,107(4):793-797. doi: 10.1097/01.AOG.0000206757.92602.b5. doi: 10.1097/01.AOG.0000206757.92602.b5
[32]	Grobman WA, Gilbert SA, Iams JD, et al. Activity restriction among women with a short cervix[J]. Obstet Gynecol, 2013,121(6):1181-1186. doi: 10.1097/AOG.0b013e3182917529. doi: 10.1097/AOG.0b013e3182917529
[33]	Society for Maternal-Fetal Medicine (SMFM), Lauder J, Sciscione A, et al. Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management: (Replaces Consult Number 33, August 2014)[J]. Am J Obstet Gynecol, 2020,223(2):B2-B10. doi: 10.1016/j.ajog.2020.04.031. doi: 10.1016/j.ajog.2020.04.031
[34]	Brocklehurst P, Gordon A, Heatley E, et al. Antibiotics for treating bacterial vaginosis in pregnancy[J]. Cochrane Database Syst Rev, 2013(1):CD000262. doi: 10.1002/14651858.CD000262.pub4. doi: 10.1002/14651858.CD000262.pub4
[35]	Thinkhamrop J, Hofmeyr GJ, Adetoro O, et al. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity[J]. Cochrane Database Syst Rev, 2015,2015(6):CD002250. doi: 10.1002/14651858.CD002250.pub3. doi: 10.1002/14651858.CD002250.pub3